oncology

Update: Immunotherapeutic options in advanced melanomaAt EADV, Dr. Simone Ribero reviews the latest data on new treatments for advanced melanoma.
Avelumab safety profile is “acceptable”Immunotherapy improves Merkel cell carcinoma, but questions remain.
First gene therapy for cancer approved: What health execs should knowThe first therapy based on gene transfer has been approved by the FDA. What’s next for healthcare executives?
Oral specialty drug options on the horizon
Oral specialty drug options on the horizonAs more specialty drugs are approved, cost control strategies are key.
Bundled payments on ‘pause,’ but not for longPolitical uncertainty plagues new payment arrangement, but private payers embrace new model.
New Cigna program aims to ‘unlock’ the value of healthcare dataCigna publication project takes a page out of the big pharma and medical technology playbook.
Cognitive computing shakes up healthcare: What execs need to know
Cognitive computing shakes up healthcare: What execs need to knowThe concepts that power cognitive computing and AI have grown to include substantial healthcare advancements.
Three improvements data promises to deliverPersonalized, prescriptive medicine creates higher-value care for patients
Managing conjunctival pigmented lesionsKnowing how to recognize and manage the various forms of conjunctival pigmented lesions can literally mean the difference between life and death in some cases.
Consider different iris lesion forms before final clinical diagnosis
Consider different iris lesion forms before final clinical diagnosisUse these pearls to better diagnose and treat iris lesions.